A Randomised Controlled Clinical Trial on the Use of a Dental Aerosol Box to Prevent Microbial Transmission During Dental Procedure

September 27, 2021 updated by: Dr Wan Nurazreena Wan Hassan, University of Malaya
The study compares the use of a dental aerosol box in preventing microbial transmission during dental procedure. Subjects requiring scaling treatment (BPE 2) will be recruited. Subjects will be allocated either into the control group (conventional suction method) or interventional group (dental aerosol box) Treatment will involve scaling of two quadrants, where data collection of the microbes will be taken. Secondary outcome will involve a self-administered questionnaire on patients acceptance over the scaling procedure either with conventional suction or using the dental aerosol box to contain the aerosol generated during the scaling procedure.

Study Overview

Detailed Description

A closed operation room, with the facility to fumigate the room is chosen for all treatment procedures. Patients would be treated with time separations that would be reasonable to prevent microbial detection of the previous patient.

Sample size calculated based on Sadun et al (2020) to compare two groups would require 15 subjects per group for a 90% power and 0.05 significance.

Inclusion criteria: BPE 2 on at least 2 quadrants. Exclusion criteria: Smoker and systemic disease.

Patients will be randomised using randomiser.org. The list will be placed in a sealed envelop by an individual not involved in subject recruitment. Patient grouping will be determined after recruitment and consent. The envelop will be opened and patient allocated to the group.

Interventional group:

  1. Conventional suction (control)
  2. Dental aerosol box with modified high-volume evacuation system (interventional)

The procedure will involve scaling of two quadrants, where data collection of the microbes will be taken.

Before each appointment, at the start of study all operatory surfaces were cleaned and disinfected with Ethyl alcohol (70%). Between each treatment and at start of treatment, ultrasonic scaler units will be flushed with water for 2 minutes. Use of 0.5% Sodium Hypochlorite will be done for flushing the tubing of dental chair waterline and the same solution would be allowed to stay in tubing for 10 minutes followed by water flushing to remove the unwanted biofilm from the tubing surfaces. This procedure would be done at the end of each treatment.

Then operatory will fumigated at the end of all procedures to allow the room to be free of aerosol before it is allowed for use for the subsequent subject. Dental unit would use distilled water in self-contained system, for the study.

i) Primary outcome: microbial colony forming unit Passive sampling will be conducted to assess the index of microbial air contamination as described in other studies (Pasquarella C, et al 2000, Napoli C, et al 2012, Saha R, et al 2017). The method quantifies the microbial flow directly related to the contamination of surfaces coming from microbes that reach critical points by falling on to them. The index of microbial air contamination is based on the count of the microbial fallout on to Petri dishes left open to the air according to the 1/1/1 scheme (for 1h, 1m from the floor, at least 1m away from walls or any obstacle). This index corresponds to the values of CFU calculated from the culture plates of 9 cm diameter. Sealed petri dishes will be transported to where the procedures will be done. Gravity settle plates using tryptic soy agar in 9cm Petri dishes will be used to assess the colony count for passive sampling. The index of microbial air contamination will be assessed at rest (in the early morning before the beginning of dental procedures) and in operational of procedures (during procedures) to determine changes in bacterial count due to dental treatment. Five resting and five in operational samples will be taken from each room. Plates will be incubated overnight at 37°C and colony counts will be documented.

ii) Secondary outcome: patient acceptance Patient will complete a self-administered questionnaire to determine their acceptance over the experience to undergo the scaling procedure.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wilayah Persekutuan
      • Kuala Lumpur, Wilayah Persekutuan, Malaysia, 50603
        • Faculty Of Dentistry, University of Malaya

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 70 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BPE score of 2

Exclusion Criteria:

  • BPE score of 1, 3 or 4
  • Smoker
  • Systemic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Active comparator: Conventional suction system
This is the conventional method of using the dental high volume suction to contain the aerosol generated during dental procedure. The saliva ejector will also be used.
This is the conventional method of using the dental high volume suction to contain the aerosol generated during dental procedure. The saliva ejector will also be used.
Experimental: Experimental: Dental aerosol box with modified high volume evacuation system
The dental aerosol box will be equipped with an exit for the high volume suction to be attached to contain the aerosol generated during dental procedure. The saliva ejector will also be used.
The dental aerosol box will be equipped with an exit for the high volume suction to be attached to contain the aerosol generated during dental procedure. The saliva ejector will also be used.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total bacterial count
Time Frame: 30 mins
The index of microbial air contamination is based on the count of the microbial fallout on to Petri dishes left open to the air according to the 1/1/1 scheme (for 1h, 1m from the floor, at least 1m away from walls or any obstacle). This index corresponds to the values of CFU calculated from the culture plates of 9 cm diameter. The index of microbial air contamination will be assessed at rest (before the beginning of dental procedures) and in operational of procedures (during procedures) to determine changes in bacterial count due to dental treatment.
30 mins

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient acceptance of dental procedure
Time Frame: 1 treatment session, which is about 30 mins
The patient will be given a questionnaire after the treatment to assess their acceptance over the treatment procedure i.e. having scaling procedure by the method (control or interventional). The perception will assessed using Likert scale.
1 treatment session, which is about 30 mins

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 6, 2021

Primary Completion (Actual)

September 27, 2021

Study Completion (Actual)

September 27, 2021

Study Registration Dates

First Submitted

July 23, 2021

First Submitted That Met QC Criteria

August 29, 2021

First Posted (Actual)

September 5, 2021

Study Record Updates

Last Update Posted (Actual)

September 29, 2021

Last Update Submitted That Met QC Criteria

September 27, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CSRG001-2020ST

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Calculi

Clinical Trials on Conventional suction system

Subscribe